Background: According to WHO, CDC, IDSA and ATS guidelines, patients with pulmonary tuberculosis (Tb) can be considered as non infectious when: 1) they are receiving multiple drugs for 2 to 3 weeks; 2) there is an improvement in clinical condition; 3) the likelihood of MDR-Tb is very small. Objective: To determine the time for sputum reversion since the start of anti-Tb treatment in prisoners from four jails in Medellin and Bucaramanga, Colombia between May 2010 to April 2011.
Background: Zambia is a high burden country for both human immunodeficiency virus (HIV) and tuberculosis (TB) infection and HIV clinic enrollees are a high-risk group for active TB. The advent of low-cost rapid-diagnostic technologies for TB, such as the Gene Xpert MTB/RIF assay and microscopic-observation drugsusceptibility (MODS) culture, suggest an affordable and promising diagnostic method to quickly identify and treat cases, but the costeffectiveness of these tests are not well-established in high burden areas with a high prevalence of HIV.
Methods: The objective of this study was to determine the costeffectiveness of different TB diagnostic strategies in a cohort of HIV-infected patients in Lusaka. A cost-effectiveness analysis (CEA) was carried out using decision analysis modeling. Using the cohort proportions of HIV clinic enrollees at the Centre for Infectious Disease Research in Zambia (CIDRZ), the analysis compared the following strategies: standard of care TB diagnosis (a combination of symptom screening, sputum smear microscopy, and chest x-ray in a diagnostic algorithm), enhanced TB screening (symptom screening, sputum smear microscopy, chest x-ray and TB culture), Gene Xpert MTB/RIF Assay, MODS, and empiric treatment. Outcomes analyzed were number of cases of active pulmonary TB diagnosed and incremental cost-effectiveness ratios (ICERS).
Results: Preliminary results from the base case analysis found that the standard of care was US$75.74 per case of TB detected, US$327.80 per case detected using enhanced screening, US$108.90 per case detected using Xpert, and US$41.74 per case detected using MODS. The ICERS ranged from US$34.00 per case averted using MODS or Xpert to US$252.00 per case averted using enhanced screening, where the standard of care was the comparison group.
Conclusion: The decision analysis model suggests that using rapid diagnostics, particularly MODS, is very cost-effective for diagnosing TB in HIV clinic enrollees in Lusaka, Zambia.
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